DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Nissen SE, Wolski K.
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

N Engl J Med 2007;
356: 2457-2471

Download Bibliographical Data

Access: